Overview
For the first time, this conference will convene key stakeholders from both the Middle East and Africa to facilitate meaningful collaboration and the development of practical solutions to shared regulatory challenges within the healthcare sector. This virtual summit signifies the beginning of an ongoing engagement between the two regions, which will be further advanced at the in-person conference scheduled for 2026.
The DIA Middle East & Africa Conference 2025 will provide a secure and inclusive platform for regulatory authorities, industry leaders, academics, and patient representatives to exchange insights and advance health outcomes. A defining feature is the active involvement of regulatory agencies from the Middle East, Africa, and beyond, with structured discussions enabling direct engagement, promoting transparency, and addressing regulatory challenges throughout the medicine lifecycle.
Key topics include regional regulatory developments, reliance, digitalisation, pharmacovigilance, and innovation.
Why you should attend:
- Collaborate with Health Authorities’ representatives and key Industry leaders from the various countries in the MEA region and contribute to shaping the future of the regulatory landscape in the region.
- Connect with 300+ participants, representing all countries in the Middle East and Africa regions and beyond.
- Discuss new strategies and processes to be implemented in the Middle East and Africa regions.
- Learn how reliance, harmonisation initiatives and collaboration contribute to an efficient and sustainable regulatory system in the Middle East and Africa regions.
Who will you meet?
- Regulatory Authorities’ representatives from the region and beyond.
- Experts from international organisations.
- Thought leaders, global and local stakeholders from both local and global organisations.
Featured
Want to learn more about Middle East & Africa Conference (MEA)? You've come to the right site!
DIA Middle East and Africa Conference
Program Committee
-
Ali Al Shibly Murad Chair - Lebanese Regulatory WG; Regulatory Affairs Senior Specialist -Levant
MSD, Lebanon -
Abdulrahim Alyahya SaudiArabia Regulatory WG; Director-Regulatory Policy, Governmental Affair & TSO
Biogen, Saudi Arabia -
Dorra Idir Chair-Tunisia Local Network WG & Chef de département affaires réglementaires PPP
Sanofi Aventis Tunisia, Tunisia -
Mounay Hussein Khafaja, PharmD, MSc Chair-Iraqi RegulatoryWG; Regulatory Affairs Director & Reg.Center of Excellence
Merck (MSG), Lebanon -
Alia Seoud Abdalla Global Regulatory Sciences Head (Africa Cluster)
Pfizer, Egypt -
Amira Deia Younes Director-Eastern Europe, Middle East & Africa (EEMEA) Global Regulatory Policy
MSD, United Arab Emirates -
Asma Messai License To Operate Enabler, Tunisia and Libya
Roche, Tunisia -
Dalia Fouad Middle East Region Head - Global Regulatory Affairs
Sanofi Aventis, United Arab Emirates -
Deema Al Naji Director, African Cluster & MEA Regulatory Policy Lead
AstraZeneca, United Arab Emirates -
Dina Fathy, MPharm, AHIP Senior Director, Regulatory Affairs Middle East Subregional Lead
MSD UAE, United Arab Emirates -
Imane Hattami Therapeutic Area Head and Regulatory Policy Intelligence MEAR
Abbvie Biopharmaceuticals Gmbh, Morocco -
May Shawky Mohamed Regional Manager Regulatory Affairs MEAR
Merck Group, United Arab Emirates -
Melly Lin, MS CMC Regulatory Policy Lead, Pharma Technical Regulatory
F. Hoffmann-La Roche Ltd, Switzerland -
Neveen Kamel Regulatory Affairs Head North Africa, Egypt & French-speaking Africa
Merck Group, Egypt -
Niveen Osman, MBA Regulatory Affairs Director Middle East & Africa
Amgen Inc., United Arab Emirates -
Patricia Salami Senior Director, Regional RA Head - MEAR (Middle East_Africa_Turkey_Russia_CIS)
Merck, United Arab Emirates -
Sara Torgal, MPharm Global Regulatory Policy Lead
DIA, Switzerland -
Zainab Aziz, MSc, RPh IFPMA ARN Co-Chair & Associate Director, Regulatory Policy Middle East & Africa
Novartis, South Africa
Have an account?